天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

Home Cart 0 Sign in  

[ CAS No. 781661-94-7 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 781661-94-7
Chemical Structure| 781661-94-7
Structure of 781661-94-7 * Storage: {[proInfo.prStorage]}

Please Login or Create an Account to: See VIP prices and availability

Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Search after Editing

* Storage: {[proInfo.prStorage]}

* Shipping: {[proInfo.prShipping]}

Quality Control of [ 781661-94-7 ]

Related Doc. of [ 781661-94-7 ]

Alternatived Products of [ 781661-94-7 ]
Product Citations

Product Details of [ 781661-94-7 ]

CAS No. :781661-94-7 MDL No. :MFCD11983133
Formula : C20H19BrN4O3 Boiling Point : -
Linear Structure Formula :- InChI Key :QBIYUDDJPRGKNJ-UHFFFAOYSA-M
M.W : 443.29 Pubchem ID :11178236
Synonyms :
Chemical Name :1-(2-Methoxyethyl)-2-methyl-4,9-dioxo-3-(pyrazin-2-ylmethyl)-4,9-dihydro-1H-naphtho[2,3-d]imidazol-3-ium bromide

Calculated chemistry of [ 781661-94-7 ]      Expand+

Physicochemical Properties

Num. heavy atoms : 28
Num. arom. heavy atoms : 17
Fraction Csp3 : 0.25
Num. rotatable bonds : 5
Num. H-bond acceptors : 5.0
Num. H-bond donors : 0.0
Molar Refractivity : 107.26
TPSA : 77.96 ?2

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : Yes
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -7.3 cm/s

Lipophilicity

Log Po/w (iLOGP) : -3.94
Log Po/w (XLOGP3) : 2.4
Log Po/w (WLOGP) : -1.65
Log Po/w (MLOGP) : -0.31
Log Po/w (SILICOS-IT) : 2.76
Consensus Log Po/w : -0.15

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -4.22
Solubility : 0.0267 mg/ml ; 0.0000603 mol/l
Class : Moderately soluble
Log S (Ali) : -3.68
Solubility : 0.0929 mg/ml ; 0.000209 mol/l
Class : Soluble
Log S (SILICOS-IT) : -5.89
Solubility : 0.000576 mg/ml ; 0.0000013 mol/l
Class : Moderately soluble

Medicinal Chemistry

PAINS : 1.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 3.44

Safety of [ 781661-94-7 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 781661-94-7 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 781661-94-7 ]

[ 781661-94-7 ] Synthesis Path-Downstream   1~1

  • 1
  • [ 355405-02-6 ]
  • [ 781661-94-7 ]
YieldReaction ConditionsOperation in experiment
With hydrogen bromide; In ethanol; water; at 50 - 60℃; for 13 - 38h;Product distribution / selectivity; Example 1; Ethanol (10 ml) suspension of N-{1,4-dioxo-3-[(pyrazin-2-ylmethyl)amino]-1,4-dihydronaphthalen-2-yl}-N-(2-methoxyethyl)acetamide (2.0 g) was mixed with 47% hydrobromic acid (1 ml) and stirred at 50C for 38 hours. After completion of the reaction, the reaction mixture was cooled to room temperature to find precipitation of crystals. This was stirred for 5 hours, and then the crystals were collected by filtration, washed with ethanol and dried to obtain the bromide (alpha-form Crystal) (2.01 g) as orange crystals.; Example 2; Ethanol (680 ml) suspension of N-{1,4-dioxo-3-[(pyrazin-2-ylmethyl)amino]-1,4-dihydronaphthalen-2-yl}-N-(2-methoxyethyl)acetamide (170 g) was mixed with 47% hydrobromic acid (85 ml) and stirred by heating at 60C for 13 hours. At the time of completing the reaction, a small amount of insoluble matter was formed. When this was heat-dissolved by adding ethanol (170 ml) and then spontaneously cooled, crystals were precipitated. They were stirred at room temperature for 24 hours and then collected by filtration and washed with ethanol to obtain 185 g (wet weight) of crude crystals. The crude crystals were recrystallized using a mixed solvent of ethanol (850 ml) and water (85 ml) to obtain the bromide (alpha-form Crystal) (104.80 g). The residue (53.6 g) obtained by concentrating the recrystallization mother liquor was mixed with water (250 ml) and dissolved therein at room temperature. The thus formed insoluble matter was removed by filtration, and the filtrate was concentrated under a reduced pressure to obtain a yellow crystalline residue (53.5 g). The residue was mixed with ethanol (250 ml), suspended and stirred at 50C for 1 hour and then stirred at room temperature for 21 hours. The crystals were collected by filtration and then washed with ethanol and dried to obtain the bromide (beta-form Crystal) (47.34 g).
With hydrogen bromide; In methanol; water; for 5h;Heating / reflux; Example 3; Methanol (25 ml) suspension of N-{1,4-dioxo-3-[(pyrazin-2-ylmethyl)amino]-1,4-dihydronaphthalen-2-yl}-N-(2-methoxyethyl)acetamide (5 g) was mixed with 47% hydrobromic acid (2.5 ml) and heated under reflux for 5 hours. After completion of the reaction, methanol (15 ml) was evaporated under ordinary pressure. When the residue was spontaneously cooled, crystals were precipitated. They were stirred at room temperature for 15 hours and then mixed with ethyl acetate (40 ml) and further stirred at room temperature for 7 hours. The crystals were collected by filtration, washed and dried to obtain the bromide (P-form Crystal) (4.61 g) as yellow crystals.
Recommend Products
Same Skeleton Products

Technical Information

Historical Records
; ;